| | |
| |  | Tuesday, April 28, 2020
| | Editor's Note: Last week, we talked about exactly how you can take back your wealth this year - leveraging one man's access to an under-the-radar market where billions of dollars change hands every single day. It all starts tomorrow at 1PM ET. Just click here to RSVP. You'll be first in line to receive all the details on this event, plus more important information. |
 | | Dear Startup Investor,
The coronavirus pandemic has thrown the global markets into complete chaos.
Industries that were doing well are suddenly tanking... and companies that weren't doing much are going bananas trying to meet demand.
Think about it... When was the last time a friend of yours wanted to buy an extremely large jigsaw puzzle... and couldn't get one?
That's just a silly example, of course - but my point is, a lot of supply chains have been turned completely upside down.
I don't see things normalizing anytime soon... At least not until a vaccine for COVID-19 is developed. It's the one benchmark everybody is waiting for. Without a vaccine, it's hard to be confident enough to start opening stores and factories.
There are nearly two dozen companies in the United States alone working to develop it right now. But many of them are running into major hurdles. Out of 20+ companies in the race, only six have made it to human trials.
One of the most promising leaders is a Massachusetts-based biotech company called Moderna. Their vaccine, mRNA-1273, could proceed to its final round of human testing this year, pending the results of the trial.
Moderna has already received more than $400 million in Federal capital to develop the product... and early results look promising.
So it should come as no surprise that investors have already come running. Moderna went public back in 2018, and its stock price has more or less hovered below $20 since then.
Well, Moderna stock is up more than 60% in the last month alone - which means its shareholders are rejoicing. But as always, if you flip back to the chapters that happened before the big IPO... you get to see a much more interesting story.
Just for kicks, I decided to do a little digging to find out how Moderna's angel investors made out. And I was not disappointed.
One of Moderna's earliest investors is a Harvard University medical professor named Timothy Springer. In fact, he's an immunologist - so he knew this company's potential when he saw it. He invested $5 million into Moderna years ago... and today, his stake is worth well over $800 million.
That's a 17,000% gain. If he'd waited until Moderna's IPO, he'd be up about 122% - an impressive return by any measure... But compared to 17,000%, it sounds a little lean, doesn't it?
My point is that angel investing remains the best (and maybe the only) way that an investor can beat the stock market by multiple orders of magnitude - even now, while the global markets are in turmoil. Timothy Springer is a billionaire now. Many angel investors before him joined the billionaire club the same way... and many more will follow.
It's easy to look back at a story like this and think, "Man, what was I doing back then? Why did I miss out?" But I can assure you that a few years from today, we'll be looking at another huge success story... And it could be one that starts right now.
Like all of life's most important events, there's never one "perfect time" to make your first angel investment. It's just one of those things - every moment could be perfect. Personally, I woke up one day and decided I was tired of watching other people get rich this way. So I stepped off the sidelines and into the game. Will you?
Until next time,
Neil |
| | Trending | | | It's Fast, Nimble, and Perfect for Right Now | | This is one of Wall Street's biggest moneymaking advantages. And tomorrow, D.R. Barton, Jr. is revealing how you can use it to your benefit. It's already paid off with 1,359% in total closed gains since October. And after his free online event, you'll come away with two trade targets to put into action. We'll send exciting information and exclusive pre-show content once you RSVP here. |
|
|
| | | Stay Connected | | Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.
© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.
Website | Privacy Policy | Terms & Conditionshttp://link.e.angelsandentrepreneurs.com/wf/unsubscribe?upn=SVR9z3LgXEwEIVbUkFIuhfIKPV96lSE9UseWeXZ52MI4WY4eEn-2FXQBTN4MGeOz0GseIyndgO8daCHIwjmPi0EySCaAsypuV8RNEMBC-2FVlkhIHWMm1hw0uSXu4GkwGu9TAayNV8TQjBBSMH1t8f3YsH-2BEq2eiGipWZqe-2B8-2FM83BW0PLWRHvzNABv2mbfX6aOk-2Fto1rod6z0rdDuo8af-2FPxOUi-2F1bCmOspAqin72q7F1oYHBjJAUHO5cQe2t7mQ-2BI1ZQxdpso-2BsDg8AnkhQfIxTUZw96DLhNPgqMhg2UU7julGNW0TLpuBD56X65Fj80F64dic2XyebZEFDvpytPbjlJWVAXTMuzGXhZexbVwzbOmu2WMi-2B-2FFO6-2Fnk-2FG5Q7Zz8Yo-2FZez-2B1T3THUc7Qxy6HDBlD7R7HOzyp717BlvLvNZJsuYk5l7sNLp-2FpzB5XQ-2FvFEVr4ZuHUblfvJl1ebefxKBUXvp9SX4FChZElWzX2nKVA9mjsz3tjRQ4N5RvVpCe4PqM-2BW3nPfK-2FmLqaollClihzo6Qg9aFQ0ynS7GObFlTTo2TYp-2BW1ac27AtfShBivN9s1ux81G86N3Lnyfqdt-2F9jVN9IuMVdUj7itRJzuhd6aIJb2kGKXrJBSExOXBrvhQgmDjdunUCMxV0zA5obnHxkNxhuhcg8PIIRRk64wD1vkJx-2FxSdrbCjjgbezbvdCV-2BGoradeAn0Uaous46z1M-2B2tXYFXhhm5tX8WElX9e2hwxpOHIAio76YK-2Bj-2B7xWwOe2LKSLmh94X9k-2B7IvM5JGveNoARnXXEwOfmV76V1XwSwdWsvvk-2BahlsgeW1CKftMSTsxVO3XgYci-2FWT7PAmvMcg-2BkB2PZT80tW4hrw1T8qlSwFOQOFndfMKigGpa36nlHKsmsSA-2FILmZFtELetmKRC6nIQRtW1nXvwFwhXZfi6oHKNUA-2BaI3Us4JTZh06u5kFwsBYK5iFwuVHu7JtZQM0QaQ-3D-3D |
|
No comments:
Post a Comment